Tadalafil is available in U.S.-approved oral tablet products with labeled strengths of 2.5 mg, 5 mg, 10 mg and 20 mg. These numbers describe how much active ingredient is in a tablet. They do not by themselves indicate which product a patient needs, whether the prescription is for erectile dysfunction or benign prostatic hyperplasia (BPH), or whether the medicine should be taken daily or as needed.
Tadalafil has an unusually broad ED/BPH labeling framework among familiar ED medicines. Lower strengths commonly appear in once-daily settings, while 10 and 20 mg have important roles in the as-needed ED framework; 5 mg also has an as-needed adjustment role under labeling. The same tablet strength may therefore require different instructions depending on the indication.
This page is a structured product-strength directory, not the medical process for selecting a dose. For clinician-guided regimen details visit tadalafil dosage; for choosing between schedules see daily versus as-needed tadalafil; for the ingredient overview read tadalafil for ED.
U.S. product labels describe four common tadalafil ED/BPH tablet strengths. The rows below show indication-related context, not a conversion chart or a list from which to select a prescription. An individual approved supplier may offer particular presentations; current pharmacy inventory must be checked separately.
A tablet’s exact manufacturer, form and approved indication are product-specific details. Keep that separate from a clinician’s decision about the patient’s daily or as-needed schedule.
| Tablet strength | Common U.S.-labeled clinical context | Detailed product page |
|---|---|---|
| 2.5 mg | Once-daily ED; also a clinician-selected starting strength for BPH/ED+BPH with specified renal impairment | Tadalafil 2.5 mg |
| 5 mg | Daily ED, BPH, ED/BPH; also some as-needed adjustments | Tadalafil 5 mg |
| 10 mg | As-needed ED framework | Tadalafil 10 mg |
| 20 mg | Clinician-directed as-needed ED adjustment | Tadalafil 20 mg |
Strength is the amount of tadalafil per tablet. Dose is what the patient is directed to take; frequency determines when it is taken; indication explains the condition being treated. These terms can coincide in simple prescriptions, but they should not be collapsed into a single tablet-choice table.
The exact directions come from a valid prescription. The tadalafil prescription guide explains the medical assessment and ordering process rather than implying that product listings can authorize a dose.
The U.S. once-daily ED label describes an initial 2.5 mg framework, with clinician adjustment to 5 mg based on effectiveness and tolerability. A daily plan is followed on a regular schedule without linking every dose to anticipated sexual activity.
This is not a suggestion that everyone needs daily medication. The separate daily tadalafil guide explains how clinicians think about the framework and what makes it distinct from as-needed ED care.
The approved tadalafil label generally identifies 5 mg once daily for BPH symptoms and for patients with both ED and BPH. However, this is not the only relevant BPH-labeled strength: for creatinine clearance of 30–50 mL/min, the label recommends starting at 2.5 mg once daily, with any subsequent adjustment to 5 mg based on clinician review of response. Those indications require clinical evaluation of urinary symptoms, medical history and potential alternative diagnoses. A lower tablet strength or different schedule cannot be inferred from a product listing.
For indication-specific details see tadalafil for ED and BPH. The presence of either 2.5 mg or 5 mg in this directory does not diagnose urinary symptoms or select a regimen. The 2.5 mg product page details the renal-specific exception; severe renal impairment or dialysis brings further restrictions that require the prescriber’s assessment.
The U.S. Cialis label describes 10 mg as a usual initial as-needed ED dose for most patients, with clinical adjustments to 5 mg or 20 mg based on response and tolerability. The dose is taken in relation to anticipated sexual activity, not as a reason for unsupervised daily use.
The as-needed tadalafil guide focuses on timing, practical directions and the limits of expectations. A larger strength does not prove greater efficacy in an individual.
Tadalafil persists in the body beyond a single short activity window, but daily treatment and as-needed treatment are studied and labeled regimens rather than equivalent sums of milligrams over time. Changing frequency or adding extra tablets can increase exposure and adverse-effect risk.
Do not convert daily to as-needed therapy or combine separate PDE5 inhibitors without medical direction. The schedule comparison addresses the actual decision criteria.
Cialis is the branded tadalafil product, while FDA-approved generics have their own product records, tablet appearances and supply chains. A recognized strength across approved labels does not mean that a particular brand package or labeler is being marketed or stocked everywhere.
Compare Cialis identity with approved generic tadalafil. Ask a pharmacist to check the exact product and legally permitted substitution.
Tadalafil is contraindicated with organic nitrates and riociguat. Medication interactions, relevant cardiovascular conditions, renal or hepatic impairment and other patient-specific factors must be evaluated before dosing decisions, whatever the tablet strength.
An erection lasting more than four hours requires emergency attention; sudden loss of vision or hearing requires prompt care. The tadalafil interactions overview and safety page provide ingredient-level context.
Tadalafil is also used in pulmonary arterial hypertension under distinct labeled products and treatment instructions. A 20 mg tablet listed for PAH cannot simply be substituted into an ED prescription because the number and ingredient match.
Before dispensing, the pharmacy should match indication-specific product identity, approved labeling and clinician instructions. The 20 mg strength guide explains that issue in more detail.
Use the valid prescription to confirm the active ingredient, indication, exact strength, regimen and quantity. Ask a licensed pharmacy to identify the dispensed brand or generic, labeler and current inventory. Then request a current complete quote under the chosen payment method.
For fulfillment and cost questions see checking tadalafil availability and evergreen cost factors. Do not select tablets or change directions based on catalog prices or promotional claims.
U.S. tadalafil ED/BPH product labels describe 2.5 mg, 5 mg, 10 mg and 20 mg tablet strengths.
The U.S. once-daily ED label includes a 2.5 mg framework with possible clinician adjustment to 5 mg.
In standard U.S. labeling, 5 mg once daily is the usual BPH and ED/BPH framework. An important exception is a 2.5 mg starting regimen in patients with creatinine clearance 30–50 mL/min, as assessed by the prescriber.
Yes. It is part of the U.S. as-needed ED dosing framework, with clinician-directed adjustments when appropriate.
No. A higher number does not guarantee the best response or safety for a given patient.
Do not assume interchangeability; the approved indications, products and regimens differ.
No. Pharmacy supply depends on the specific approved product and dispensing location.
A qualified clinician selects the prescription after considering indication, medical history, interactions and response; the strength directory is not a dosing recommendation.